<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04367558</url>
  </required_header>
  <id_info>
    <org_study_id>0010-20-HYMC</org_study_id>
    <nct_id>NCT04367558</nct_id>
  </id_info>
  <brief_title>Minimal Surgical Treatment for Obstructive Sleep Apnea (OSA)</brief_title>
  <official_title>Possible Efficacy of Minimal Surgical Treatment for Obstructive Sleep Apnea (OSA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hillel Yaffe Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hillel Yaffe Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obstructive Sleep apnea carries a variety of complications and implications. While the
      disease could be treated using continuous positive airway pressure (CPAP) and lifestyle
      changes, many patients find it difficult to adjust to the mask, and turn to surgical options.
      The conventional surgical options to date ranges from radical (UPPP) to individualized, with
      or without Drug-induced sleep endoscopy (DISE). Previous studies showed that dise directed
      surgery can be useful for specific conditions. No trials were found to test in-office
      encompassing minimal invasive surgical treatment (RF palatoplasty , RF tonsillotomy, RF
      turbinectomy, and RF base-of-tongue reduction) as a viable alternative..
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2020</start_date>
  <completion_date type="Anticipated">May 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>More than 50% improvement in Apnea-Hypopnea index (AHI)</measure>
    <time_frame>6 months following the procedure</time_frame>
    <description>Measuring the AHI score using sleep laboratory</description>
  </primary_outcome>
  <primary_outcome>
    <measure>More than 50% improvement in Apnea-Hypopnea index (AHI)</measure>
    <time_frame>12 months following the procedure</time_frame>
    <description>Measuring the AHI score using sleep laboratory</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reduction of AHI to below 20</measure>
    <time_frame>6 months following the procedure</time_frame>
    <description>Measuring the AHI score using sleep laboratory</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reduction of AHI to below 20</measure>
    <time_frame>12 months following the procedure</time_frame>
    <description>Measuring the AHI score using sleep laboratory</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Sleep Apnea Syndromes, Obstructive</condition>
  <arm_group>
    <arm_group_label>Interventional</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient suffering from OSA, and found to suffer from obstruction of one or more of the following areas - Lower turbines, Soft Palate, Tonsils, Base-of-tongue.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Minimally invasive, in-office, RF reduction of the affected area</intervention_name>
    <description>Usage of RF needle to treat one or more of the affected areas</description>
    <arm_group_label>Interventional</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients suffering from OSA, defined as AHI &gt; 5

        Exclusion Criteria:

          -  Patients who can use CPAP.

          -  Patients suffering from confounding factors with higher risk (Coagulation problems,
             Heart conditions, chronic obstructive pulmonary disease (COPD), or other dangerous
             conditions as decided by the surgeon)

          -  Patients suffering from other problems aggravating the OSA (Respiratory, Neurologic
             conditions)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>110 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Itzhak Braverman, MD</last_name>
    <phone>972-4-7744664</phone>
    <email>braverman@hy.health.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Isaac Shochat, MD</last_name>
    <phone>972-4-7744664</phone>
    <email>isaacs@hy.health.gov.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hillel Yaffe MC,</name>
      <address>
        <city>Hadera</city>
        <zip>38100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Itzhak Braverman, MD</last_name>
      <phone>972-4-630-4549</phone>
      <email>braverman@hy.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Itzhak Braverman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 27, 2020</study_first_submitted>
  <study_first_submitted_qc>April 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 29, 2020</study_first_posted>
  <last_update_submitted>May 26, 2020</last_update_submitted>
  <last_update_submitted_qc>May 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

